Chickenpox Vaccine Has Nearly Erased Deaths, Hospitalizations From Virus in U.S.
FRIDAY, Oct. 21, 2022 (HealthDay News) — New government data shows that the chickenpox vaccine has virtually eliminated deaths and severe cases of the virus in U.S. children and teens.In the analysis, released Thursday by the U.S. Centers for Disease…
Learn MorePersistent Racial/Ethnic Disparities Seen in Flu Vaccine Coverage
FRIDAY, Oct. 21, 2022 (HealthDay News) — Racial and ethnic disparities in U.S. influenza hospital rates and influenza vaccination coverage persist, according to research published in the Oct. 18 issue of the U.S. Centers for Disease Control and Preve…
Learn MoreRates of Health Care Use Higher After Positive SARS-CoV-2 Test
FRIDAY, Oct. 21, 2022 (HealthDay News) — The rates of health care use are significantly higher after a positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) test than after a negative test, according to a study published online Oct. 1…
Learn MoreStudy Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial s…
Learn MoreStudy Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial s…
Learn MoreSe acerca una dura temporada de gripe, y los CDC esperan que las minorías se vacunen más
MARTES, 18 de octubre de 2022 (HealthDay News) — Es una ecuación problemática: muchos estadounidenses con las tasas más altas de hospitalización por la influenza tienen la adopción más baja de la vacuna anual contra la gripe.Por esto, los Centros par…
Learn MoreCOVID Shot After SARS-CoV-2 Recovery in Pregnancy Ups Antibodies in Infants
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — For women with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pregnancy, vaccination after recovery is associated with increased odds of detectable immunoglobulin (Ig)G in infants, accordin…
Learn MoreComenzará en África un importante ensayo de TPOXX, el tratamiento para la viruela del simio
LUNES, 17 de octubre de 2022 (HealthDay News) — La capacidad de TPOXX de tratar a las personas infectadas con la viruela del simio se va a evaluar de forma directa en un nuevo ensayo en África Central, anunciaron las autoridades de salud de EE. UU. T…
Learn MoreAs Tough Flu Season Looms, CDC Hopes for More Flu Shots Among Minorities
TUESDAY, Oct. 18, 2022 (HealthDay News) — It’s a troubling equation: Many Americans with the highest rates of hospitalization for influenza have the lowest uptake of the annual flu vaccine.That’s why the U.S. Centers for Disease Control and Preventio…
Learn MoreMajor Trial of Monkeypox Treatment TPOXX to Launch in Africa
MONDAY, Oct. 17, 2022 (HealthDay News) — The ability of TPOXX to treat people infected with monkeypox is being directly tested in a new clinical trial in Central Africa, U.S. health officials have announced.TPOXX — the antiviral drug tecovirimat — …
Learn More